Inhibitory transmission in guinea pig stomach mediated by distinct receptors for pituitary adenylate cyclase-activating peptide. 1996

S Katsoulis, and W E Schmidt, and R Schwarzhoff, and U R Folsch, and J G Jin, and J R Grider, and G M Makhlouf
Department of Medicine, Medical College of Virginia, Richmond, USA.

Previous studies have shown that inhibitory transmission in guinea pig stomach involves an interplay between vasoactive intestinal peptide (VIP) and nitric oxide (NO). The present study examined the contribution of pituitary adenylate cyclase-activating peptide (PACAP), a homologous peptide present in gastric and intestinal myenteric neurons. VIP, PACAP-27 and PACAP-38 induced concentration-dependent relaxation that was partly inhibited by the antagonists VIP10-28 and PACAP6-38 and the NO synthase inhibitor NG-nitro-L-arginine (L-NNA). Only relaxation induced by PACAP-27 and PACAP-38 was partly inhibited by apamin. Electrical field stimulation (0.25-16 Hz) induced frequency-dependent relaxation and PACAP release (maximum of 35.7 fmol/100 mg-min or 7-fold above basal levels). Electrical field stimulation-induced relaxation was partly inhibited by a combination of selective monoclonal antibodies to PACAP-27 and PACAP-38 (42 +/- 7% at 16 Hz) and by the antagonists VIP10-28 (29 +/- 9%) and PACAP6-38 (29 +/- 3%). The relaxation was also partly inhibited by L-NNA (51 +/- 12% at 16 Hz) and apamin (36 +/- 4%). The effects of a combination of apamin and L-NNA were additive, amounting to 75 +/- 3% inhibition. The effect of L-NNA reflected inhibition of NO release from nerve terminals, as well as NO generation in muscle cells by the action of VIP and PACAP; the effect of apamin reflected blockade of the action of PACAP. Thus, inhibitory transmission in guinea pig gastric fundus represents the combined actions of VIP, PACAP and NO released from nerve terminals and NO generated in muscle cells. The postjunctional actions of PACAP are mediated by a VIP/PACAP-II receptor and by a PACAP-specific, apamin-sensitive receptor.

UI MeSH Term Description Entries
D009126 Muscle Relaxation That phase of a muscle twitch during which a muscle returns to a resting position. Muscle Relaxations,Relaxation, Muscle,Relaxations, Muscle
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D011979 Receptors, Pituitary Hormone Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system. Pituitary Hormone Receptors,Receptors, Pituitary Hormones,Pituitary Hormones Receptors
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013270 Stomach An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM. Stomachs
D051219 Pituitary Adenylate Cyclase-Activating Polypeptide A multi-function neuropeptide that acts throughout the body by elevating intracellular cyclic AMP level via its interaction with PACAP RECEPTORS and VASOACTIVE INTESTINAL PEPTIDE RECEPTOR. Although first isolated from hypothalamic extracts and named for its action on the pituitary, it is widely distributed in the central and peripheral nervous systems. PACAP is important in the control of endocrine and homeostatic processes, such as secretion of pituitary and gut hormones and food intake. PACAP,PACAP-27,PACAP-38,PACAP27,PACAP38,Pituitary Adenylate Cyclase Activating Polypeptide,Pituitary Adenylate Cyclase Activating Polypeptide 27,Pituitary Adenylate Cyclase Activating Polypeptide 38
D051236 Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide A family of G-protein-coupled receptors that share significant homology with GLUCAGON RECEPTORS. They bind PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE with high affinity and trigger intracellular changes that influence the behavior of CELLS. PACAP Receptors,Pituitary Adenylate Cyclase-Activating Peptide Receptors,PACAP Receptor,Pituitary Adenylate Cyclase-Activating Peptide Receptor,Receptor, PACAP,Pituitary Adenylate Cyclase Activating Peptide Receptor,Pituitary Adenylate Cyclase Activating Peptide Receptors,Receptors, PACAP,Receptors, Pituitary Adenylate Cyclase Activating Polypeptide
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

S Katsoulis, and W E Schmidt, and R Schwarzhoff, and U R Folsch, and J G Jin, and J R Grider, and G M Makhlouf
January 1998, Pulmonary pharmacology & therapeutics,
S Katsoulis, and W E Schmidt, and R Schwarzhoff, and U R Folsch, and J G Jin, and J R Grider, and G M Makhlouf
August 1995, The Journal of clinical endocrinology and metabolism,
S Katsoulis, and W E Schmidt, and R Schwarzhoff, and U R Folsch, and J G Jin, and J R Grider, and G M Makhlouf
November 1991, Regulatory peptides,
S Katsoulis, and W E Schmidt, and R Schwarzhoff, and U R Folsch, and J G Jin, and J R Grider, and G M Makhlouf
April 2000, European journal of pharmacology,
S Katsoulis, and W E Schmidt, and R Schwarzhoff, and U R Folsch, and J G Jin, and J R Grider, and G M Makhlouf
October 1992, Trends in endocrinology and metabolism: TEM,
S Katsoulis, and W E Schmidt, and R Schwarzhoff, and U R Folsch, and J G Jin, and J R Grider, and G M Makhlouf
July 1998, The European respiratory journal,
S Katsoulis, and W E Schmidt, and R Schwarzhoff, and U R Folsch, and J G Jin, and J R Grider, and G M Makhlouf
June 1998, Endocrinology,
S Katsoulis, and W E Schmidt, and R Schwarzhoff, and U R Folsch, and J G Jin, and J R Grider, and G M Makhlouf
November 1993, The Journal of clinical endocrinology and metabolism,
S Katsoulis, and W E Schmidt, and R Schwarzhoff, and U R Folsch, and J G Jin, and J R Grider, and G M Makhlouf
April 2018, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,
S Katsoulis, and W E Schmidt, and R Schwarzhoff, and U R Folsch, and J G Jin, and J R Grider, and G M Makhlouf
October 2005, European journal of pharmacology,
Copied contents to your clipboard!